These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32199028)

  • 21. Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis.
    Rahim T; Becquart P; Baeva ME; Quandt J
    J Neuroinflammation; 2018 Sep; 15(1):270. PubMed ID: 30231889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
    Fetisova E; Chernyak B; Korshunova G; Muntyan M; Skulachev V
    Curr Med Chem; 2017; 24(19):2086-2114. PubMed ID: 28302008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of Central Remyelination and Treatment Evolution in a Model of Multiple Sclerosis with Optic Coherence Tomography.
    Benítez-Fernández R; Melero-Jerez C; Gil C; de la Rosa EJ; Martínez A; de Castro F
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.
    Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Espejo C; Álvarez-Cermeño JC; Villar LM; Guaza C
    Front Immunol; 2019; 10():1374. PubMed ID: 31258540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic strategies in multiple sclerosis: a focus on neuroprotection and repair and relevance to schizophrenia.
    Inglese M; Petracca M
    Schizophr Res; 2015 Jan; 161(1):94-101. PubMed ID: 24893901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ibudilast for the treatment of multiple sclerosis.
    Goodman AD; Gyang T; Smith AD
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1231-7. PubMed ID: 27501293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
    Rottlaender A; Kuerten S
    Int J Mol Sci; 2015 Jul; 16(7):14850-65. PubMed ID: 26140377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
    Cudkowicz ME; van den Berg LH; Shefner JM; Mitsumoto H; Mora JS; Ludolph A; Hardiman O; Bozik ME; Ingersoll EW; Archibald D; Meyers AL; Dong Y; Farwell WR; Kerr DA;
    Lancet Neurol; 2013 Nov; 12(11):1059-67. PubMed ID: 24067398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune-mediated neurodegeneration and neuroprotection in MS.
    Giuliani F; Yong VW
    Int MS J; 2003 Dec; 10(4):122-30. PubMed ID: 14977489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG; Voda J; Yu X; McKeon G; Bourdette DN
    J Neurosci Res; 2004 Aug; 77(3):367-77. PubMed ID: 15248293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
    Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroprotection therapy of multiple sclerosis with high doses of ethylmethylhydroxypyridine succinate].
    Prakhova LN; Ilves AG; Savintceva ZI; Mineev KK; Nikiforova IG; Rubanik KS; Kataeva GV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10 Pt 2):73-78. PubMed ID: 28139615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment.
    Ouallet JC
    Rev Neurol (Paris); 2020 Jun; 176(6):500-504. PubMed ID: 32278541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexpramipexole is ineffective in two models of ALS related neurodegeneration.
    Vieira FG; LaDow E; Moreno A; Kidd JD; Levine B; Thompson K; Gill A; Finkbeiner S; Perrin S
    PLoS One; 2014; 9(12):e91608. PubMed ID: 25526593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and needs in experimental therapies for multiple sclerosis.
    Lutterotti A
    Curr Opin Neurol; 2018 Jun; 31(3):263-267. PubMed ID: 29608446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodegeneration and neuroprotection in multiple sclerosis.
    Stangel M
    Curr Pharm Des; 2012; 18(29):4471-4. PubMed ID: 22612743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
    Levy Barazany H; Barazany D; Puckett L; Blanga-Kanfi S; Borenstein-Auerbach N; Yang K; Peron JP; Weiner HL; Frenkel D
    Exp Neurol; 2014 May; 255():63-70. PubMed ID: 24552689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.
    Silbermann E; Wooliscroft L; Bourdette D
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):49. PubMed ID: 29923130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.